PolyActiva develops products that enable drug release from medical devices.
PolyActiva has raised $25.7M in total funding. The most recent round was Series C. The last funding was announced in May 2025.
PolyActiva's investors include Brandon Capital, National Reconstruction Fund Corporation, Medical Research Future Fund (MRFF), Yuuwa Capital, Medical Research Commercialisation Fund (MRCF).
PolyActiva is headquartered in Melbourne, Australia.
PolyActiva develops products that enable drug release from medical devices.
PolyActiva is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PolyActiva — Funding & Investors." VCBacked, May 30, 2025, https://www.vcbacked.co/company/polyactiva. Accessed September 3, 2026.
VCBacked. (2025). PolyActiva — Funding & Investors. Retrieved September 3, 2026, from https://www.vcbacked.co/company/polyactiva
{{cite web |title=PolyActiva — Funding & Investors |url=https://www.vcbacked.co/company/polyactiva |website=VCBacked |access-date=September 3, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated